Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke

Rock Creek Pharmaceuticals, Inc.109 enrolled

Overview

This study will consist of 2 phases. Phase 1 will be a one day crossover study to see the effects of study product on a smoker's desire to smoke, measured by changes in scores on questionnaires given over time. Phase 2 will be a two-week extension, in which subjects will self-administer the study product and visit the study site for assessment of desire to smoke and collection of samples for the evaluation of smoking-related biomarkers.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

109

Conditions

Tobacco Use Disorder Tobacco Dependence Smoking

Interventions

one dissolvable bit, one time, after a period of abstinence from smoking

CigRx(R)DIETARY_SUPPLEMENT

one dissolvable bit, one time, after a period of abstinence from smoking

Eligibility

Sex: ALLMin age: 23 YearsMax age: 72 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy adult smokers * using at least 1 pack of cigarettes per day, for at least 5 years Exclusion Criteria: * allergy to study product components

Locations (1)

Comfort Inn

Martinsburg, West Virginia, United States

Outcomes

Primary Outcomes

effect on subject's craving to smoke

craving is assessed by changes in questionnaire answers over time

Time frame: 5 hours

Secondary Outcomes

adverse events related to study product

collection of information on adverse events related to study product

Time frame: 5 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.